Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma

NCT00294632 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Lenalidomide
DRUG: Rituximab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]